Heska Corporation
HSKA
$119.99
Share price
0.00%
Change (1 day)
29.80%
Change (1 year)
Categories
Heska Corporation (HSKA) - P/B ratio
P/B ratio as of April 2024 : 3.14
According to Heska Corporation
's latest financial reports the company has a price-to-book ratio of 3.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Heska Corporation - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 1.59 | -64.46% |
| 2021-12-31 | 4.48 | -6.73% |
| 2020-12-31 | 4.81 | -1.85% |
| 2019-12-31 | 4.90 | -9.26% |
| 2018-12-31 | 5.40 | -6.67% |
| 2017-12-31 | 5.78 | 1.87% |
| 2016-12-31 | 5.68 | 40.77% |
| 2015-12-31 | 4.03 | 86.4% |
| 2014-12-31 | 2.16 | 114.48% |
| 2013-12-31 | 1.01 | 13.3% |
| 2012-12-31 | 0.8906 | 12.79% |
| 2011-12-31 | 0.7896 | 39.37% |
| 2010-12-31 | 0.5666 | -7.23% |
| 2009-12-31 | 0.6107 | 100.37% |
| 2008-12-31 | 0.3048 | -86.12% |
| 2007-12-31 | 2.20 | -82.63% |
| 2006-12-31 | 12.6 | -37.26% |
| 2005-12-31 | 20.1 | -9.92% |
| 2004-12-31 | 22.4 | 32.61% |
| 2003-12-31 | 16.9 | 828.27% |
| 2002-12-31 | 1.82 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.25 | 35.64% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | -48.64% | 🇺🇸 USA |
 Eli Lilly LLY | 64.1 | 1,944.78% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 27.9 | 790.90% | 🇺🇸 USA |
 Zoetis ZTS | 14.5 | 362.62% | 🇺🇸 USA |
 Merck MRK | 8.83 | 181.62% | 🇺🇸 USA |
 Petco WOOF | 0.3424 | -89.08% | 🇺🇸 USA |